The loss of Inspire Medical Systems under GAAP for 9 months of 2020 amounted to $49.719 million, having doubled compared to $24.163 million in the previous year. Revenue increased by 25.8% to $69.372 million against $55.144 million a year earlier.
The loss of Inspire Medical Systems under GAAP for 9 months of 2020 amounted to $49.719 million, having doubled compared to $24.163 million in the previous year. Revenue increased by 25.8% to $69.372 million against $55.144 million a year earlier. 
English (US) 